<div id="readability-page-1"><p>Braidwell LP acquired a new position in  Globus Medical, Inc. (NYSE:GMED - Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities &amp; Exchange Commission. The firm acquired 247,200 shares of the medical device company's stock, valued at approximately $14,590,000. Braidwell LP owned 0.18% of Globus Medical as of its most recent SEC filing.</p><div><p><span></span><span>Get <strong>Globus Medical</strong> alerts:</span></p></div><p>Other hedge funds also recently made changes to their positions in the company. Brevan Howard Capital Management LP bought a new stake in  Globus Medical during the 2nd quarter worth approximately $547,000.  Blue Capital Inc. purchased a new stake in shares of  Globus Medical in the second quarter worth $443,000.  Ameriprise Financial Inc. raised its position in shares of  Globus Medical by 24.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 205,173 shares of the medical device company's stock valued at $12,109,000 after purchasing an additional 40,090 shares during the period.  AQR Capital Management LLC raised its position in shares of  Globus Medical by 397.6% during the 2nd quarter. AQR Capital Management LLC now owns 112,001 shares of the medical device company's stock valued at $6,595,000 after purchasing an additional 89,491 shares during the period.  Finally, Quantinno Capital Management LP lifted its stake in shares of  Globus Medical by 79.4% during the 2nd quarter. Quantinno Capital Management LP now owns 13,450 shares of the medical device company's stock valued at $794,000 after buying an additional 5,952 shares in the last quarter. 95.16% of the stock is currently owned by institutional investors. </p><h2>Insiders Place Their Bets</h2><p>In other Globus Medical news, Director Stephen T. Zarrilli sold 25,000 shares of the business's stock in a transaction that occurred on Tuesday, November 11th. The stock was sold at an average price of $84.29, for a total transaction of $2,107,250.00. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, SVP Kelly Huller sold 7,500 shares of the company's stock in a transaction that occurred on Tuesday, November 25th. The shares were sold at an average price of $90.00, for a total value of $675,000.00. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 96,042 shares of company stock worth $8,003,630. Insiders own  18.51% of the company's stock. </p><h2>Analyst Upgrades and Downgrades</h2><p>A number of brokerages have issued reports on GMED. Stifel Nicolaus started coverage on Globus Medical in a research note on Tuesday, October 28th. They issued a &#34;hold&#34; rating and a $64.00 price target for the company. Wells Fargo &amp; Company upped their price objective on Globus Medical from $66.00 to $79.00 and gave the stock an &#34;overweight&#34; rating in a research note on Friday, November 7th. Zacks Research downgraded Globus Medical from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research note on Tuesday. Truist Financial  reissued a &#34;buy&#34; rating and issued a $105.00 price target (up from $93.00) on shares of Globus Medical in a report on Tuesday, November 18th. Finally, Barclays upped their price target on Globus Medical from $106.00 to $114.00 and gave the stock an &#34;overweight&#34; rating in a research note on Monday, November 10th. Nine investment analysts have rated the stock with a Buy rating and six have issued  a Hold rating to the company's stock. According to data from MarketBeat, Globus Medical  has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $93.00.</p><p><b>View Our Latest Analysis on GMED</b></p><h2>Globus Medical Trading Down 2.4%</h2><p>Shares of GMED stock opened at $86.77 on Friday. The stock has a market capitalization of $11.61 billion, a price-to-earnings ratio of 27.99, a price-to-earnings-growth ratio of 1.64 and a beta of 1.07. Globus Medical, Inc. has a 12-month low of $51.79 and a 12-month high of $94.93. The stock's 50-day moving average price is $74.46 and its 200-day moving average price is $63.77. </p><p>Globus Medical (NYSE:GMED - Get Free Report) last announced its quarterly earnings results on Thursday, November 6th. The medical device company reported $1.18 EPS for the quarter, beating analysts' consensus estimates of $0.79 by $0.39. Globus Medical had a return on equity of 11.52% and a net margin of 15.30%.The company had revenue of $769.05 million during the quarter, compared to analyst estimates of $734.58 million. During the same period in the prior year, the company earned $0.83 earnings per share. The firm's revenue was up 22.9% on a year-over-year basis. Globus Medical has set its FY 2025 guidance at 3.750-3.85 EPS.  As a group, research analysts predict that  Globus Medical, Inc. will post 3.44 EPS for the current fiscal year. </p><h2>About Globus Medical</h2> (Free Report)<p>Globus Medical, Inc, a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Globus Medical</li><li>How to Capture the Benefits of Dividend Increases</li><li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li><li>What is the Shanghai Stock Exchange Composite Index?</li><li>The Best Holiday Present You Can Give Yourself? Costco Stock</li><li>The Top 3 Healthcare Dividend Stocks to Buy and Hold</li><li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li></ul><p><strong>Want to see what other hedge funds are holding GMED?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globus Medical, Inc. (NYSE:GMED - Free Report).</p><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUdNRUQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Globus Medical Right Now?</h2><p>Before you consider Globus Medical, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globus Medical wasn't on the list.</p><p>While Globus Medical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

GMED

<p>Braidwell LP acquired 247,200 shares of Globus Medical, valued at $14.59 million, during Q2. Other hedge funds also adjusted their positions. Insiders sold shares worth $8 million. Analysts have mixed ratings, with a consensus of 'Moderate Buy' and an average target price of $93. Globus Medical's stock opened at $86.77, with a market cap of $11.61 billion. The company reported strong quarterly earnings, beating estimates with $1.18 EPS and $769.05 million revenue, up 22.9% YoY.</p>

Braidwell LP Purchases Shares of 247,200 Globus Medical, Inc. $GMED